Forest Investigative Site 1803 — Pembroke Pines, Florida

Forest Investigative Site 1803 is a clinical research site located in Pembroke Pines, Florida, United States 32028.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Forest Investigative Site 1803 has participated in 2 clinical trials.

Therapeutic areas: Chronic Obstructive Pulmonary Disease.

Sponsors: AstraZeneca.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 1803?

Forest Investigative Site 1803 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 1803 conducted?

Forest Investigative Site 1803 has 2 clinical trials on record. Their work covers Chronic Obstructive Pulmonary Disease.

Is Forest Investigative Site 1803 accredited by Crixeo Health?

Forest Investigative Site 1803 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 1803?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.